Vulcan Two Group PLC
VUL · AIM · Personal Care, Drug and Grocery Stores · mcap £56m · 215.0p
The company runs online pharmacy brands, with an ePharmacy platform at molecule.co.uk. It sells medicines and treatments to consumers and plans to add a veterinary offering for businesses.
- Revenue
- –
- Operating profit
- –
- Net income
- –
- Free cash flow
- –
- Net cash
- £5.7m
- Market cap
- £58.6m
- EV / EBIT
- –
- FCF yield
- –
- Price / book
- 1.3×
- Revenue
- £10.0m –
- Operating profit
- −£4.1m prior −£80k
- Net income
- −£4.2m prior −£80k
- Cash from operations
- −£5.8m prior −£13k
Extracted automatically from the company's results announcements; check the source before relying on a figure. Not investment advice.
Interim Results and Name Change to Molecule Group, published 29 Sep 26 · read the announcement ↗
Condensed Consolidated Statement of Comprehensive Income
| Six months ended 30 June 2026 £ | Six months ended 30 June 2025 £ | |
|---|---|---|
| Revenue | 10,033,336 | - |
| Cost of sales | (7,874,327) | - |
| Gross Profit | 2,159,009 | - |
| Administrative expenses | (3,469,936) | (79,892) |
| Exceptional costs | (2,773,887) | - |
| Loss from operations | (4,084,814) | (79,892) |
| Finance income | 44,205 | - |
| Finance expense | (25,469) | - |
| Loss before tax | (4,066,078) | (79,892) |
| Taxation | (137,329) | - |
| Loss for the period | (4,203,407) | (79,892) |
| Total other comprehensive income | - | - |
| Total comprehensive loss for the period | (4,203,407) | (79,892) |
| Earnings per share attributable to the ordinary equity holders of the company | ||
| Basic and Diluted loss per share (£) | (0.2028) | (0.1031) |
Condensed Consolidated Statement of Financial Position
| As at 30 June 2026 £ | As at 31 December 2025 £ | |
|---|---|---|
| Assets | ||
| Non-current assets | ||
| Intangible assets | 44,218,128 | - |
| Right-of-use assets | 1,556,916 | - |
| Property, plant and equipment | 182,779 | 2,832 |
| Total non-current assets | 45,957,823 | 2,832 |
| Current assets | ||
| Trade and other receivables | 3,988,146 | 492,950 |
| Inventories | 1,358,375 | - |
| Cash and cash equivalents | 5,693,545 | 9,548,003 |
| Total current assets | 11,040,066 | 10,040,953 |
| Total assets | 56,997,889 | 10,043,785 |
| Liabilities | ||
| Non-current liabilities | ||
| Lease liabilities | 1,389,735 | - |
| Deferred tax liabilities | 4,257,894 | - |
| Deferred consideration | 344,159 | - |
| Total non-current liabilities | 5,991,788 | - |
| Current liabilities | ||
| Trade and other payables | 4,874,750 | 364,929 |
| Lease liabilities | 120,979 | - |
| Current tax liabilities | 1,567,940 | - |
| Deferred consideration | 12 | 189,564 |
| Total current liabilities | 6,753,233 | 364,929 |
| Total liabilities | 12,745,021 | 364,929 |
| Net assets | 44,252,868 | 9,678,856 |
| Equity | ||
| Share capital | 2,727,500 | 677,500 |
| Share premium | 46,881,956 | 10,229,510 |
| Merger reserve | 70,004 | 70,004 |
| Share-based payment reserve | 121,959 | 46,986 |
| Accumulated losses | (5,548,551) | (1,345,144) |
| Total equity | 44,252,868 | 9,678,856 |
As published in the company's results announcement: every line, heading and subtotal, read automatically from the text. Figures in brackets are negative; units as stated in the column headings.
Latest report: H1 26 (six months to 30 Jun 26), published 29 Sep 26 · read the results ↗
£m unless stated · newest first · italic = calculated (LTM, H2 = FY − H1) · hover a value for its source
| H1 26 | vs H1 25 | H1 25 | |
|---|---|---|---|
| Revenue to operating profit | |||
| Revenue | 10.0 | – | – |
| Gross profit | 2.2 | – | – |
| Exceptional / adjusting items | (2.8) | – | – |
| Operating profit | (4.1) | n/m | (0.1) |
| Amortisation | 0.6 | – | – |
| Share-based payments | 0.1 | – | – |
| Operating profit to net income | |||
| Finance costs | (0.0) | – | – |
| Profit before tax | (4.1) | n/m | (0.1) |
| Tax | (0.1) | – | – |
| Net income (owners) | (4.2) | n/m | (0.1) |
| Per share | |||
| EPS basic | (20.3p) | – | (10.3p) |
| EPS diluted | (20.3p) | – | (10.3p) |
| Latest Jun 26 | FY 25 | |
|---|---|---|
| Non-current assets | ||
| Goodwill | 27.2 | – |
| Property, plant & equipment | 0.2 | 0.0 |
| Non-current assets | 46.0 | 0.0 |
| Current assets | ||
| Inventories | 1.4 | 0.0 |
| Trade receivables | 4.0 | 0.5 |
| Cash | 5.7 | 9.5 |
| Current assets | 11.0 | 10.0 |
| Total assets | 57.0 | 10.0 |
| Current liabilities | ||
| Trade payables | 4.9 | 0.4 |
| Lease liabilities, current | 0.1 | – |
| Current liabilities | 6.8 | 0.4 |
| Non-current liabilities | ||
| Lease liabilities, non-current | 1.4 | – |
| Non-current liabilities | 6.0 | 0.0 |
| Total liabilities | 12.7 | 0.4 |
| Equity | ||
| Total equity | 44.3 | 9.7 |
| H1 26 | H2 25 | |
|---|---|---|
| Non-current assets | ||
| Goodwill | 27.2 | – |
| Property, plant & equipment | 0.2 | 0.0 |
| Non-current assets | 46.0 | 0.0 |
| Current assets | ||
| Inventories | 1.4 | 0.0 |
| Trade receivables | 4.0 | 0.5 |
| Cash | 5.7 | 9.5 |
| Current assets | 11.0 | 10.0 |
| Total assets | 57.0 | 10.0 |
| Current liabilities | ||
| Trade payables | 4.9 | 0.4 |
| Lease liabilities, current | 0.1 | – |
| Current liabilities | 6.8 | 0.4 |
| Non-current liabilities | ||
| Lease liabilities, non-current | 1.4 | – |
| Non-current liabilities | 6.0 | 0.0 |
| Total liabilities | 12.7 | 0.4 |
| Equity | ||
| Total equity | 44.3 | 9.7 |
Line items extracted automatically from each results announcement; when a later report restates a period, the later figure is shown. LTM and H2 are calculated from reported periods. Check the source before relying on a figure.
Company filings. Not investment advice.